AirSculpt Technologies

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AirSculpt Technologies reports robust Q4 performance and eyes margin expansion

AirSculpt Technologies demonstrated strong financial performance in Q4 2022, with revenue and case volumes showing significant growth.
The company's strategic focus on margin expansion, new offerings, and growth drivers like talent acquisition bode well for future success.
While challenges around cost management and achieving targeted margins exist, opportunities in optimizing operations and driving revenue growth present avenues for advancement.

AirSculpt Technologies reports solid Q1 growth amidst margin challenges

AirSculpt Technologies delivered a strong Q1 2023 performance with revenue growth, stable pricing, and financial stability, positioning the company for continued growth.
While facing challenges in margin decline and flat same-store case growth forecast, the company's focus on cost management and operational efficiency presents opportunities for improvement and expansion.
Overall, AirSculpt's resilience in the face of economic pressures, coupled with its strategic outlook on market dynamics and innovations, sets a positive trajectory for future growth and profitability.

AirSculpt Technologies reports robust Q2 results and eyes market expansion

AirSculpt Technologies delivered strong Q2 results, showcasing revenue growth and market expansion through new procedures like AirSculpt Lift.
While challenges such as pricing, competition, and hiring exist, the company remains focused on driving profitability and achieving revenue targets.
With a strategic focus on innovation and market opportunities, AirSculpt Technologies is poised for continued growth and success in the aesthetic technology sector.

AirSculpt Technologies reports strong Q3 earnings, eyes growth opportunities ahead

AirSculpt Technologies showcased robust financial performance in Q3, raising revenue and adjusted EBITDA guidance for 2023. The company's focus on growth strategies, cost management, and product demand bode well for future success. Analyst inquiries highlighted areas for potential improvement and strategic focus to drive continued growth.

AirSculpt Technologies reports robust Q4 earnings and outlines growth strategies

AirSculpt Technologies' Q4 2023 earnings call showcased strong financial performance, growth in revenue and EBITDA, successful expansion efforts, and a positive outlook for 2024. While challenges exist in addressing various concerns, the company is well-positioned to capitalize on opportunities for further growth and success.

AirSculpt Technologies reports Q1 growth but faces profitability challenges

AirSculpt Technologies reported mixed performance in Q1 2024 with revenue growth but declining same-store center sales.
The company faces challenges in maintaining profitability amidst cost increases and margin pressures.
Opportunities lie in improving same-store center performance, cost management, and leveraging marketing strategies for growth.
Overall, AirSculpt's strategic outlook and focus on expansion indicate resilience and potential for future success.

AirSculpt Technologies reports Q2 revenue decline, focuses on cost efficiency

AirSculpt Technologies faced revenue and EBITDA declines in Q2 2024 but is focusing on cost management and performance marketing for future growth.
Operational strengths include a physical presence in 28 centers and potential to capitalize on increased lead volumes.
Challenges lie in managing SG&A expenses and addressing lower conversion rates, requiring strategic adjustments.
Opportunities exist in improving marketing strategies, reducing costs, and leveraging consumer trends for expansion.

AirSculpt Technologies reports Q3 revenue decline but boosts 2024 guidance

AirSculpt Technologies navigated challenges with a focus on lead conversion, new centers, and cost management, reflecting adaptability and growth potential.
Despite a revenue decline, the company's strategic initiatives and increased guidance indicate confidence in future performance and expansion.
Opportunities in customer engagement, new locations, and payment options position AirSculpt for sustained growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Kadant

Mondee Holdings Inc

scPharmaceuticals

Trupanion

Verrica Pharmaceuticals Inc

Westrock Coffee Holdings LLC

Short-squeeze stocks represent one of the boldest forms of contrarianism available. Simply put, it's a showdown between the bears that are attempting to profit from the downturn of a public enterprise.

7 Short-Squeeze Stocks That Could Beat Down the Bears

Beam Global

Easily one of the most explosive ideas to consider in the market are short-squeeze stocks to buy. This niche area plays on the psychology of panicked emotions.

3 Short-Squeeze Stocks to Buy Before July for 20% Returns

AirSculpt Technologies (AIRS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher

AirSculpt Technologies (AIRS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround

AirSculpt Technologies, Inc. (NASDAQ:AIRS ) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Dennis Dean - Chief Financial Officer Todd Magazine - Chief Executive Officer Conference Call Participants Josh Raskin - Devin Research Korinne Wolfmeyer - Piper Sandler John Ransom - Raymond James Operator Hello, and welcome to the AirSculpt Technologies, Inc. First Quarter 2024 Earnings Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.

AirSculpt Technologies, Inc. (AIRS) Q1 2024 Earnings Call Transcript

The headline numbers for AirSculpt Technologies (AIRS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics

AirSculpt Technologies, Inc. (AIRS) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago.

AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates

MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024.

AirSculpt Technologies Reports for First Quarter Earnings

Evaluate the expected performance of AirSculpt Technologies (AIRS) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

MIAMI BEACH, Fla. , April 29, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced the relocation of its Atlanta office to 3391 Peachtree Road NE Suite 100, Atlanta, GA 30326 from 3495 Piedmont Road.

AirSculpt® Relocates and Expands to New Location to Meet Market Demand

LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or "the Company") (NASDAQ:AIRS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AirSculpt Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or "the Company") (NASDAQ:AIRS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AirSculpt Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK , March 19, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ: AIRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

MIAMI BEACH, Fla. , March 19, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, has partnered with Kristen Doute, reality personality, podcast host, entrepreneur and star of Bravo's The Valley and Vanderpump Rules, to share her AirSculpt® journey.

AirSculpt® Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client

LOS ANGELES, CA / ACCESSWIRE / March 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or "the Company") (NASDAQ:AIRS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against AirSculpt Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Estimates have ticked on down for this year and next year though EPS growth remains.

Bear of the Day: AirSculpt (AIRS)

Theravance Biopharma

The life of a bearish speculator can be dangerous and that's part of the appeal of short-squeeze stocks: you can make life miserable for those attempting to cynically extract profits from others' misery. At the most elemental level, I suppose it's like watching a lion eating a safari hunter.

Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics

The premium body contouring provider has reimagined its footprint adding more space for patient care, new services, and a limited time promotion MIAMI BEACH, Fla. , March 4, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced the expansion and redesign of its Scottsdale location to 9500 E.

AirSculpt® Technologies, Inc. Expands Its Scottsdale Location

While the top- and bottom-line numbers for AirSculpt Technologies, Inc. (AIRS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings

AirSculpt Technologies, Inc. (AIRS) Q4 2023 Earnings Call Transcript

AirSculpt Technologies, Inc. (AIRS) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.07 per share a year ago.

AirSculpt Technologies, Inc. (AIRS) Q4 Earnings and Revenues Miss Estimates

MIAMI BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and full year ended December 31, 2023.

AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for AirSculpt Technologies, Inc. (AIRS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.

What Analyst Projections for Key Metrics Reveal About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings

Shares of AirSculpt Technologies fell 30% on Friday after Fuzzy Panda Research revealed a short position in the cosmetic surgery firm.

Airsculpt shares slide after Fuzzy Panda takes short position

MIAMI BEACH, Fla., Jan. 31, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced it will report fourth quarter 2023 financial results before market open on Tuesday, February 27, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

News for AirSculpt Technologies Stock (AIRS)